Viewing StudyNCT00860639



Ignite Creation Date: 2024-05-05 @ 9:19 PM
Last Modification Date: 2024-10-26 @ 10:02 AM
Study NCT ID: NCT00860639
Status: COMPLETED
Last Update Posted: 2017-01-27
First Post: 2009-03-11

Brief Title: Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia AML With Intermediate Risk
Sponsor: Nantes University Hospital
Organization: Nantes University Hospital

Conditions & Keywords Data

Conditions:
Name
Acute Myeloid Leukemia
Keywords:
Name View
gemtuzumab ozogamycin View
AML View